Patent · US Active

Injectable fibrin composition for bone augmentation

US9724449B2 · kind B2 · utility

0Cited by

21References

23Claims

0Family size

Assignees

Baxter International Inc. · US
Baxter Healthcare SA · CH

Inventors

John J. Barry · Wien, AT
Andreas Goessl · Wien, AT
Heinz Gulle · Enzersdorf, AT
Monika Mangold · Wien, AT
Melitta Bilban · Wien, AT

Key dates

Filing date	Aug 17, 2015
Grant date	Aug 8, 2017
Priority date	—
Expiry date	Nov 19, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61L2430/02
WIPO fieldMedical technology
WIPO sectorInstruments

Abstract

The present invention relates to a biodegradable injectable composition for bone augmentation comprising fibrin, a contrast agent and calcium salt-containing particles, as well as a method for bone augmentation in a patient suffering from a bone disorder comprising injecting said composition into a non-mineralized or hollow portion of said bone.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.